norethindrone acetate has been researched along with Body Weight in 11 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After three treatment cycles body weight increased in both treatment groups by between 500 and 700 g." | 2.68 | Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern. ( Lübbert, H; Nauert, C, 1997) |
| "Buserelin-treated rats developed similarly depressed plasma oestradiol-17 beta values in the presence and absence of progestogen, and both groups given buserelin had significantly smaller uteri than controls or rats given norethindrone without buserelin." | 1.29 | Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia. ( Gold, E; Goulding, A, 1993) |
| " One month after ovariectomy, the rats were dosed once daily for 6 months with either a low dose of growth hormone (GH) (0." | 1.29 | Growth hormone normalizes vertebral strength in ovariectomized rats. ( Andreassen, TT; Eschen, C, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Chen, X | 1 |
| Gong, X | 1 |
| He, D | 1 |
| Cheng, X | 1 |
| Prabahar, K | 2 |
| Hernández-Wolters, B | 2 |
| Velu, P | 1 |
| Du, W | 1 |
| Lan, X | 1 |
| Cai, S | 1 |
| Li, G | 1 |
| Yin, Y | 1 |
| Burkman, RT | 1 |
| Fisher, AC | 1 |
| Wan, GJ | 1 |
| Barnowski, CE | 1 |
| LaGuardia, KD | 1 |
| Suparto, IH | 1 |
| Koudy Williams, J | 1 |
| Fox, JL | 1 |
| Vinten-Johansen, J | 1 |
| Koninckx, PR | 1 |
| Spielmann, D | 1 |
| Yüksel, H | 1 |
| Odabaşi, AR | 1 |
| Demircan, S | 1 |
| Karul, A | 1 |
| Kozaci, LD | 1 |
| Köseoğlu, K | 1 |
| Kizilkaya, K | 1 |
| Başak, O | 1 |
| Tugrul, S | 1 |
| Yildirim, G | 1 |
| Pekin, O | 1 |
| Uslu, H | 1 |
| Kutlu, T | 1 |
| Eren, S | 1 |
| Goulding, A | 1 |
| Gold, E | 1 |
| Eschen, C | 1 |
| Andreassen, TT | 1 |
| Lübbert, H | 1 |
| Nauert, C | 1 |
| Haarbo, J | 1 |
| Leth-Espensen, P | 1 |
| Stender, S | 1 |
| Christiansen, C | 1 |
2 reviews available for norethindrone acetate and Body Weight
| Article | Year |
|---|---|
The effect of 17beta-estradiol plus norethisterone acetate on anthropometric indices: A systematic review and meta-analysis of randomized controlled trials.
Topics: Body Weight; Dietary Supplements; Estradiol; Humans; Norethindrone Acetate; Obesity; Randomized Cont | 2023 |
Effects of Transdermal 17β-Estradiol + Norethisterone Acetate on Cardiovascular Disease Risk Factors in Postmenopausal Women: A Meta-analysis of Data From Randomized, Controlled Trials.
Topics: Administration, Cutaneous; Blood Glucose; Body Weight; Cardiovascular Diseases; Cholesterol, LDL; Es | 2023 |
5 trials available for norethindrone acetate and Body Weight
| Article | Year |
|---|---|
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Hu | 2009 |
A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
Topics: Administration, Oral; Adult; Body Weight; Double-Blind Method; Drug Administration Schedule; Drug Co | 2005 |
Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
Topics: Administration, Oral; Adult; Aged; Body Composition; Body Mass Index; Body Weight; Double-Blind Meth | 2006 |
Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.
Topics: Adult; Body Weight; Cholesterol; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Thera | 2007 |
Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Body Weight; Cohort Studies; Estradiol; Estr | 1997 |
4 other studies available for norethindrone acetate and Body Weight
| Article | Year |
|---|---|
A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy.
Topics: Animals; Biomarkers; Blood Flow Velocity; Blood Pressure; Body Weight; Contraceptive Agents, Female; | 2005 |
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Buserelin; Calcium; Disease Models, Animal; Estradio | 1993 |
Growth hormone normalizes vertebral strength in ovariectomized rats.
Topics: Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Disease Models, Animal; Estradiol; Fem | 1995 |
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Aorta; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dru | 1991 |